Overview

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Status:
Completed

Trial end date:
2005-03-01

Target enrollment:

Participant gender:

Summary

This study evaluates the use of Targretin capsules (bexarotene) in combination with standard chemotherapy for the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in patients who have not yet received chemotherapy for their lung cancer.

Phase:

Phase 3

Details

Lead Sponsor:

Eisai Inc.

Treatments:

Albumin-Bound Paclitaxel
Bexarotene
Carboplatin
Paclitaxel